Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.900
-0.020 (-0.41%)
Nov 20, 2024, 4:00 PM EST - Market closed
Vanda Pharmaceuticals Employees
Vanda Pharmaceuticals had 203 employees as of December 31, 2023. The number of employees decreased by 87 or -30.00% compared to the previous year.
Employees
203
Change (1Y)
-87
Growth (1Y)
-30.00%
Revenue / Employee
$940,187
Profits / Employee
-$80,729
Market Cap
285.71M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AngioDynamics | 748 |
OraSure Technologies | 638 |
Sage Therapeutics | 487 |
Nautilus Biotechnology | 167 |
Voyager Therapeutics | 162 |
iTeos Therapeutics | 157 |
C4 Therapeutics | 145 |
ClearPoint Neuro | 107 |
VNDA News
- 8 days ago - Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences - PRNewsWire
- 14 days ago - Vanda Pharmaceuticals Inc. (VNDA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results - PRNewsWire
- 19 days ago - Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst - Benzinga
- 21 days ago - Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024 - PRNewsWire
- 5 weeks ago - Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal from Cycle Group Holdings Ltd. - PRNewsWire
- 5 weeks ago - Cycle Pharma maintains takeover offer for Vanda Pharmaceuticals - Reuters
- 5 weeks ago - Cycle Pharmaceuticals Reaffirms All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 Per Share - Business Wire